ALTI vs RARE · rev $131.1M vs rev $350.0M
Alvarium Tiedemann Holdings Inc. (ALTI) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Alvarium Tiedemann Holdings Inc. (ALTI) is a asset management company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported ALTI revenue for 2026-06-30 was $131.1M. Net income was -$15.8M. Revenue was up 79.4% from 2026-03-31 to 2026-06-30. ALTI currently screens at market cap $451.8M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
ALTI currently screens at market cap $451.8M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the ALTI and RARE stock pages for the full models.
Not investment advice.